[1]
2024. Neoadjuvant Concurrent Chemoradiation for High-Risk Adult Soft Tissue Sarcoma - 19 Years of a Single Institution Experience. Portuguese Journal of Oncology. 7, 1-2 (Jun. 2024), 18–24.